We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.75B
AUM Growth
+$244M
Cap. Flow
+$1.32M
Cap. Flow %
0.05%
Top 10 Hldgs %
34.07%
Holding
425
New
34
Increased
204
Reduced
126
Closed
25

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$27.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.11M
3
XOM icon
ExxonMobil
XOM
+$8.66M
4
UNH icon
UnitedHealth
UNH
+$7.74M
5
NEE icon
NextEra Energy
NEE
+$5.7M

Sector Composition

Rank Sector Weight
1 Technology 25.02%
2 Financials 10.77%
3 Healthcare 10.07%
4 Consumer Discretionary 8.12%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBIO icon
176
BridgeBio Pharma
BBIO
$16.1B
$3.5M 0.13%
81,064
-22,254
-22% -$809K
TOL icon
177
Toll Brothers
TOL
$14.5B
$3.48M 0.13%
30,496
+512
+2% +$53.1K
PRGS icon
178
Progress Software
PRGS
$1.73B
$3.47M 0.13%
54,408
+271
+0.5% +$16.5K
UTWO icon
179
US Treasury 2 Year Note ETF
UTWO
$484M
$3.47M 0.13%
71,547
+67,001
+1,474% +$3.24M
ICUI icon
180
ICU Medical
ICUI
$4.16B
$3.43M 0.12%
25,958
+149
+0.6% +$20.2K
LPLA icon
181
LPL Financial
LPLA
$28.3B
$3.39M 0.12%
9,046
+468
+5% +$164K
AXSM icon
182
Axsome Therapeutics
AXSM
$11B
$3.36M 0.12%
+32,216
New +$3.41M
LIVN icon
183
LivaNova
LIVN
$4.29B
$3.36M 0.12%
74,606
+12,964
+21% +$535K
RDNT icon
184
RadNet
RDNT
$5.27B
$3.33M 0.12%
58,579
+782
+1% +$42.9K
SLNO
185
DELISTED
Soleno Therapeutics
SLNO
$3.31M 0.12%
39,541
-11,226
-22% -$840K
IBP icon
186
Installed Building Products
IBP
$6.51B
$3.29M 0.12%
18,233
+24
+0.1% +$3.99K
IEFA icon
187
iShares Core MSCI EAFE ETF
IEFA
$194B
$3.26M 0.12%
39,051
KAI icon
188
Kadant
KAI
$3.98B
$3.18M 0.12%
10,032
-2,254
-18% -$706K
VNT icon
189
Vontier
VNT
$4.73B
$3.16M 0.11%
85,715
+417
+0.5% +$14.2K
AVNT icon
190
Avient
AVNT
$3.48B
$3.01M 0.11%
93,028
+413
+0.4% +$14.3K
NEE icon
191
NextEra Energy
NEE
$179B
$2.98M 0.11%
42,922
-82,044
-66% -$5.7M
HMN icon
192
Horace Mann Educators
HMN
$2.1B
$2.88M 0.1%
+67,022
New +$2.82M
EVR icon
193
Evercore
EVR
$12.3B
$2.87M 0.1%
10,618
+374
+4% +$82.3K
CMCSA icon
194
Comcast
CMCSA
$87.8B
$2.86M 0.1%
80,054
+4,932
+7% +$171K
MAA icon
195
Mid-America Apartment Communities
MAA
$15.7B
$2.85M 0.1%
+19,237
New +$3M
PFE icon
196
Pfizer
PFE
$147B
$2.82M 0.1%
116,489
+6,472
+6% +$151K
UNH icon
197
UnitedHealth
UNH
$375B
$2.8M 0.1%
8,979
-20,257
-69% -$7.74M
EOG icon
198
EOG Resources
EOG
$71.5B
$2.79M 0.1%
23,301
+709
+3% +$81K
TVTX icon
199
Travere Therapeutics
TVTX
$5.84B
$2.78M 0.1%
187,734
+40,269
+27% +$667K
ALLY icon
200
Ally Financial
ALLY
$13.6B
$2.77M 0.1%
71,222
+3,774
+6% +$131K

Similar funds

F/M Investments's Q2 2025 Portfolio in Review

As of Q2 2025, F/M Investments held 425 positions worth $2.75B, up 9.7% from $2.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

F/M Investments's Q2 2025 filing shows 34 new, 204 increased, 126 reduced and 25 closed positions. Its largest new stake was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M. The largest sale was Coca-Cola, an estimated $27.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • F/M Investments's largest Q2 2025 buy was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M.
  • F/M Investments added most to F/m US Treasury 3 Month Bill Fund in Q2 2025, an estimated $12M increase.
  • F/M Investments's biggest Q2 2025 reduction was Coca-Cola, cutting an estimated $27.9M.
  • F/M Investments fully exited Thermo Fisher Scientific in Q2 2025, selling an estimated $9.11M.
  • F/M Investments's ten largest holdings make up 34% of its $2.75B portfolio in Q2 2025.
  • F/M Investments opened 34 new positions and closed 25 in Q2 2025.
  • F/M Investments's portfolio value rose 9.7% quarter-over-quarter to $2.75B.

Based on F/M Investments's 13F filing for Q2 2025, filed 13 Aug 2025.